Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Ophthalmology|September 12, 2009
Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasisAnne Marie Lane, Kathleen M Egan, David Harmon, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 10, 2011
ROCK1 as a potential therapeutic target in osteosarcomaXianzhe Liu, Edwin Choy, Francis J Hornicek, et al.
Plos One|September 11, 2009
ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.
Anti-Cancer Drugs|March 15, 2011
Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivoXianzhe Liu, Edwin Choy, David Harmon, et al.
Cancer Letters|September 7, 2013
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cellsBin Jia, Edwin Choy, Gregory Cote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan, Jianming Zhang, Edwin Choy, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 22, 2015
Clinical and biological significance of PIM1 kinase in osteosarcomaYunfei Liao, Yong Feng, Jacson Shen, et al.
Oncotarget|April 19, 2017
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cellsYunfei Liao, Lulu Chen, Yong Feng, et al.
Molecular Oncology|February 2, 2017
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivoZhenfeng Duan, Yan Gao, Jacson Shen, et al.
Pageof 5